Single biomarkers, such as CEA, CA199, miR‐21, miR‐181c, MTA3, S100A2, and ezrin,5, 16, 17, 18, 20, 21 for the prognosis of recurrence in stage II CRC patients have been reported before. This evidence concerns the gene EZR and colorectal carcinoma.